Twist Bioscience Corporation Common Stock (TWST)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$2.97 (+5.90%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Twist Bioscience Corporation Common Stock (TWST)
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Key Insights

Critical company metrics and information
  • Share Price

    $52.35
  • Market Cap

    $3.11 Billion
  • Total Outstanding Shares

    59.36 Million Shares
  • Total Employees

    923
  • Dividend

    No dividend
  • IPO Date

    October 31, 2018
  • SIC Description

    Biological Products, (no Disgnostic Substances)
  • Homepage

    https://www.twistbioscience.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Operating Activities, Continuing$-64.09 Million
Net Cash Flow From Operating Activities$-64.09 Million
Net Cash Flow From Investing Activities, Continuing$-3.07 Million
Net Cash Flow From Investing Activities$-3.07 Million
Exchange Gains/Losses$126000.00
Net Cash Flow, Continuing$-60.27 Million
Net Cash Flow From Financing Activities, Continuing$6.89 Million
Net Cash Flow From Financing Activities$6.89 Million
Net Cash Flow$-60.15 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Income Tax Expense/Benefit$560000.00
Benefits Costs and Expenses$521.14 Million
Costs And Expenses$533.80 Million
Net Income/Loss$-208.73 Million
Diluted Earnings Per Share$3.60
Operating Expenses$354.18 Million
Net Income/Loss Attributable To Parent$-208.73 Million
Selling, General, and Administrative Expenses$218.40 Million
Cost Of Revenue$179.63 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Basic Earnings Per Share$3.60
Preferred Stock Dividends And Other Adjustments$0.00
Revenues$312.97 Million
Operating Income/Loss$-220.83 Million
Other Operating Expenses$44.93 Million
Income/Loss From Continuing Operations After Tax$-208.73 Million
Diluted Average Shares$58.02 Million
Net Income/Loss Available To Common Stockholders, Basic$-208.73 Million
Research and Development$90.85 Million
Income Tax Expense/Benefit, Deferred$0.00
Income/Loss From Continuing Operations Before Tax$-208.17 Million
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Basic Average Shares$58.02 Million
Gross Profit$133.35 Million
Income Tax Expense/Benefit, Current$560000.00

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Assets$614.32 Million
Other Current Assets$322.70 Million
Current Liabilities$71.01 Million
Equity Attributable To Parent$472.69 Million
Equity$472.69 Million
Inventory$24.08 Million
Accounts Payable$1.63 Million
Wages$33.65 Million
Fixed Assets$102.52 Million
Liabilities And Equity$614.32 Million
Noncurrent Assets$267.55 Million
Equity Attributable To Noncontrolling Interest$0.00
Noncurrent Liabilities$70.63 Million
Liabilities$141.63 Million
Other Current Liabilities$35.73 Million
Current Assets$346.78 Million
Other Non-current Assets$165.03 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Related Companies

View additional S&P 500 companies similar to Twist Bioscience Corporation Common Stock (TWST)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.